Document is current
Any future updates will be listed below
-
Authors
Nigi, Laura
Pagano, Raffaella
Sarti, Francesca
Sebastiani, Guido
Dotta, Francesco
-
Funding
Funding for this research was provided by:
Italian Ministry of University and Research (MUR) PNRR ‘National Center for Gene Therapy and Drugs based on RNA Technology (CN00000041 CN3 Spoke #5 ‘Inflammatory and Infectious Diseases’)
Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance' (T4-AN-07, PAN-HUB)
Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance' (T4-AN-07, PAN-HUB)
Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance' (T4-AN-07, PAN-HUB)
Italian Ministry of University and Research (PNC 0000001 D3 4 Health)
Italian Ministry of University and Research (PNC 0000001 D3 4 Health)
Italian Ministry of University and Research (MUR) PNRR ‘National Center for Gene Therapy and Drugs based on RNA Technology’ (CN00000041 CN3 Spoke #5 ‘Inflammatory and Infectious Diseases’)
Italian Ministry of University and Research (MUR) PNRR ‘National Center for Gene Therapy and Drugs based on RNA Technology’ (CN00000041 CN3 Spoke #5 ‘Inflammatory and Infectious Diseases’)
- License Information
-
More Information
Article History
Received: 19 February 2026
Accepted: 3 April 2026
First Online: 4 May 2026
Declarations
:
: The authors declare no competing interests.
